H. Greim, G. Csanady, J. Filser, P. Kreuzer, L. Schwarz et al., Biomarkers as tools in human health risk assessment, Clin Chem, vol.41, pp.1804-1808, 1995.

A. Conney, Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture, Cancer Res, vol.42, pp.4875-917, 1982.

P. Gehring and G. Blau, Mechanisms of carcinogenesis: dose response, J Environ Pathol Toxicol, vol.1, pp.163-179, 1977.

D. Hoel, N. Kaplan, and M. Anderson, Implication of nonlinear kinetics on risk estimation in carcinogenesis, Science, vol.219, issue.4588, pp.1032-1037, 1983.
DOI : 10.1126/science.6823565

F. Johannsen, Risk Assessment of Carcinogenic and Noncarcinogenic Chemicals, Critical Reviews in Toxicology, vol.18, issue.84, pp.341-367, 1990.
DOI : 10.1080/00022470.1983.10465651

M. Anderson, D. Hoel, and N. Kaplan, A general scheme for the incorporation of pharmacokinetics in low-dose risk estimation for chemical carcinogenesis: Example???Vinyl chloride, Toxicology and Applied Pharmacology, vol.55, issue.1, pp.154-161, 1980.
DOI : 10.1016/0041-008X(80)90231-8

R. Sharma and R. Coulombe, Pharmacokinetics and Risk Assessment In: Toxicology and Risk Assessment; Principles, pp.81-99, 1996.

N. Page, D. Singh, W. Farland, J. Goodman, R. Conolly et al., Implementation of EPA Revised Cancer Assessment Guidelines: Incorporation of Mechanistic and Pharmacokinetic Data, Toxicological Sciences, vol.37, issue.1, pp.16-36, 1997.
DOI : 10.1093/toxsci/37.1.16

A. Bailer and D. Dankovic, An introduction to the use of physiologically based pharmacokinetic models in risk assessment, Statistical Methods in Medical Research, vol.91, issue.4, pp.341-358, 1997.
DOI : 10.1177/096228029700600404

M. Gargas, M. Medinsky, and M. Andersen, Pharmacokinetic Modeling Approaches for Describing the Uptake, Systemic Distribution, and Disposition of Inhaled Chemicals, Critical Reviews in Toxicology, vol.150, issue.3, pp.237-254, 1995.
DOI : 10.1080/15287399109531480

M. Andersen, H. Clewell, . Iii, M. Gargas, F. Smith et al., Physiologically based pharmacokinetics and the risk assessment process for methylene chloride, Toxicology and Applied Pharmacology, vol.87, issue.2, pp.185-205, 1987.
DOI : 10.1016/0041-008X(87)90281-X

W. Cronin, E. Oswald, M. Shelley, J. Fisher, and C. Flemming, A Trichloroethylene Risk Assessment Using a Monte Carlo Analysis of Parameter Uncertainty in Conjunction with Physiologically-Based Pharmacokinetic Modeling, Risk Analysis, vol.15, issue.5, pp.555-565, 1995.
DOI : 10.1016/0041-008X(90)90357-Z

M. Kohn and R. Melnick, Effects of the structure of a toxicokinetic model of butadiene inhalation exposure on computed production of carcinogenic intermediates, Toxicology, vol.113, issue.1-3, pp.31-39, 1996.
DOI : 10.1016/0300-483X(96)03424-5

K. Watanabe and F. Bois, Interspecies Extrapolation of Physiological Pharmacokinetic Parameter Distributions, Risk Analysis, vol.75, issue.6, pp.741-754, 1996.
DOI : 10.1016/0378-4274(93)90103-5

I. Adler, J. Cochrane, S. Osterman-golkar, T. Skopek, M. Sorsa et al., 1,3-Butadiene working group report, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.330, issue.1-2, pp.101-114, 1995.
DOI : 10.1016/0027-5107(95)00038-K

J. Morris, D. Robinson, T. Vollmuth, R. Brown, and B. Domeyer, A Parallelogram Approach for Safety Evaluation of Ingested Acetaldehyde, Regulatory Toxicology and Pharmacology, vol.24, issue.3, pp.251-263, 1996.
DOI : 10.1006/rtph.1996.0138

M. Kohn, Achieving credibility in risk assessment models, Toxicology Letters, vol.79, issue.1-3, pp.107-114, 1995.
DOI : 10.1016/0378-4274(95)03362-O

C. Portier and N. Kaplan, Variability of Safe Dose Estimates When Using Complicated Models of the Carcinogenic Process, Toxicological Sciences, vol.13, issue.3, pp.533-544, 1989.
DOI : 10.1093/toxsci/13.3.533

D. Farrar, A. B. Crump, K. Shipp, and A. , Evaluation of uncertainty in input parameters to pharmacokinetic models and the resulting uncertainty in output, Toxicology Letters, vol.49, issue.2-3, pp.371-385, 1989.
DOI : 10.1016/0378-4274(89)90044-1

F. Bois, L. Zeise, and T. Tozer, Precision and sensitivity of pharmacokinetic models for cancer risk assessment: Tetrachloroethylene in mice, rats, and humans, Toxicology and Applied Pharmacology, vol.102, issue.2, pp.300-315, 1990.
DOI : 10.1016/0041-008X(90)90029-T

B. Allen, T. Covington, and H. Clewell, Investigation of the impact of pharmacokinetic variability and uncertainty on risks predicted with a pharmacokinetic model for chloroform, Toxicology, vol.111, issue.1-3, pp.289-303, 1996.
DOI : 10.1016/0300-483X(96)03383-5

T. Woodruff, F. Bois, D. Auslander, and R. Spear, Structure and Parameterization of Pharmacokinetic Models: Their Impact on Model Predictions, Risk Analysis, vol.8, issue.2, pp.189-201, 1992.
DOI : 10.1016/0378-4274(91)90157-2

J. Gearhart, D. Mahle, R. Greene, C. Seckel, C. Flemming et al., Variability of physiologically based pharmacokinetic (PBPK) model parameters and their effects on PBPK model predictions in a risk assessment for perchloroethylene (PCE), Toxicology Letters, vol.68, issue.1-2, pp.131-144, 1993.
DOI : 10.1016/0378-4274(93)90126-I

R. Spear and F. Bois, Parameter variability and the interpretation of physiologically based pharmacokinetic modeling results, Environmental Health Perspectives, vol.102, issue.Suppl 11, pp.61-66, 1994.
DOI : 10.1289/ehp.94102s1161

D. Krewski, Y. Wang, S. Bartlett, and K. Krishnan, Uncertainty, Variability, and Sensitivity Analysis in Physiological Pharmacokinetic Models, Journal of Biopharmaceutical Statistics, vol.19, issue.3, pp.245-271, 1995.
DOI : 10.2307/2289528

R. Thomas, P. Bigelow, T. Keefe, and R. Yang, Variability in Biological Exposure Indices Using Physiologically Based Pharmacokinetic Modeling and Monte Carlo Simulation, American Industrial Hygiene Association Journal, vol.57, issue.1, pp.23-32, 1996.
DOI : 10.1080/15428119691015188

T. Louis, Assessing, Accommodating, and Interpreting the Influences of Heterogeneity, Environmental Health Perspectives, vol.90, pp.215-222, 1991.
DOI : 10.2307/3430871

A. Smith and J. Evans, Metabolic Constants for Chloroform, Toxicological Sciences, vol.25, issue.1, pp.29-44, 1995.
DOI : 10.1093/toxsci/25.1.29

L. Balant and M. Gex-fabry, Review Physiological pharmacokinetic modelling, Xenobiotica, vol.18, issue.11, pp.1241-1257, 1990.
DOI : 10.3109/03602538409033558

J. Fernandez, P. Droz, B. Humbert, and J. Caperos, Trichloroethylene exposure. Simulation of uptake, excretion, and metabolism using a mathematical model., Occupational and Environmental Medicine, vol.34, issue.1, pp.43-55, 1977.
DOI : 10.1136/oem.34.1.43

M. Andersen and J. Ramsey, A physiologically-based description of the inhalation pharmacokinetics of styrene monomer in rats and humans, Toxicology Letters, vol.18, pp.415-418, 1983.
DOI : 10.1016/0378-4274(83)90559-3

P. Droz and M. Guillemin, Human styrene exposure, International Archives of Occupational and Environmental Health, vol.32, issue.2, pp.19-36, 1983.
DOI : 10.1007/BF00406174

W. Ritschel and P. Banerjee, Physiological pharmacokinetic models: principles, applications, limitations and outlook, Methods Find Exp Clin Pharmacol, vol.8, pp.603-614, 1986.

D. Gray, A Physiologically Based Pharmacokinetic Model for Methyl Mercury in the Pregnant Rat and Fetus, Toxicology and Applied Pharmacology, vol.132, issue.1, pp.91-102, 1995.
DOI : 10.1006/taap.1995.1090

M. Kohn, The Importance of Anatomical Realism for Validation of Physiological Models of Disposition of Inhaled Toxicants, Toxicology and Applied Pharmacology, vol.147, issue.2, pp.448-458, 1997.
DOI : 10.1006/taap.1997.8289

F. Bois, A. Gelman, J. Jiang, D. Maszle, L. Zeise et al., Population toxicokinetics of tetrachloroethylene, Archives of Toxicology, vol.70, issue.6, pp.347-355, 1996.
DOI : 10.1007/s002040050284

URL : https://hal.archives-ouvertes.fr/ineris-00969532

A. Gelman, F. Bois, and J. Jiang, Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior Distributions, Journal of the American Statistical Association, vol.55, issue.436, pp.1400-1412, 1996.
DOI : 10.2307/2533402

M. Angelo, K. Bischoff, A. Pritchard, and M. Presser, A physiological model for the pharmacokinetics of methylene chloride in B6C3F1 mice following i.v. administrations, Journal of Pharmacokinetics and Biopharmaceutics, vol.6, issue.4, pp.413-436, 1984.
DOI : 10.1007/BF01062666

R. Lutz, R. Dedrick, D. Tuey, G. Sipes, M. Anderson et al., Comparison of the pharmacokinetics of several polychlorinated biphenyls in mouse, rat, dog, and monkey by means of a physiological pharmacokinetic model, Drug Metab Dispos, vol.12, pp.527-535, 1984.

G. Johanson, Physiologically based pharmacokinetic modeling of inhaled 2-butoxyethanol in man, Toxicology Letters, vol.34, issue.1, pp.23-31, 1986.
DOI : 10.1016/0378-4274(86)90141-4

H. Rao and D. Brown, A Physiologically Based Pharmacokinetic Assessment of Tetrachloroethylene in Groundwater for a Bathing and Showering Determination, Risk Analysis, vol.8, issue.1, pp.37-49, 1993.
DOI : 10.1016/0041-008X(88)90030-0

A. Roy, C. Weisel, P. Lioy, and P. Georgopoulos, A Distributed Parameter Physiologically-Based Pharmacokinetic Model for Dermal and Inhalation Exposure to Volatile Organic Compounds, Risk Analysis, vol.31, issue.6, pp.147-160, 1996.
DOI : 10.1016/0041-008X(90)90324-N

I. Åstrand, Effect of physical exercise on uptake, distribution and elimination of vapors in man In: Modeling of Inhalation Exposure to Vapors: Uptake, Distribution, and Elimination (Fiserova-Bergerova F, ed), Boca Raton, pp.107-130, 1983.

O. Flaherty, E. Scott, W. Schreiner, C. Beliles, and R. , A physiologically based kinetic model of rat and mouse gestation: Disposition of a weak acid, Toxicology and Applied Pharmacology, vol.112, issue.2, pp.245-256, 1992.
DOI : 10.1016/0041-008X(92)90194-W

R. Luecke, W. Wosilait, B. Pearce, and J. Young, A physiologically based pharmacokinetic computer model for human pregnancy, Teratology, vol.56, issue.2, pp.90-103, 1994.
DOI : 10.1002/tera.1420490205

O. Flaherty and E. , Physiologically Based Pharmacokinetic Models in Developmental Toxicology, Risk Analysis, vol.104, issue.4, pp.605-611, 1994.
DOI : 10.1007/BF01060056

K. Terry, B. Elswick, F. Welsch, and R. Conolly, Development of a Physiologically Based Pharmacokinetic Model Describing 2-Methoxyacetic Acid Disposition in the Pregnant Mouse, Toxicology and Applied Pharmacology, vol.132, issue.1, pp.103-114, 1995.
DOI : 10.1006/taap.1995.1091

O. Flaherty, E. Polák, J. Andriot, and M. , Incorporation of Temporal Factors Into Physiologically Based Kinetic Models for Risk Assessment, Inhalation Toxicology, vol.12, issue.6, pp.917-925, 1995.
DOI : 10.1289/ehp.747155

F. Welsch, G. Blumenthal, and R. Conolly, Physiologically based pharmacokinetic models applicable to organogenesis: extrapolation between species and potential use in prenatal toxicity risk assessments, Toxicology Letters, vol.82, issue.83, pp.539-547, 1995.
DOI : 10.1016/0378-4274(95)03499-4

R. Luecke, W. Wosilait, B. Pearce, and J. Young, A computer model and program for xenobiotic disposition during pregnancy, Computer Methods and Programs in Biomedicine, vol.53, issue.3, pp.201-224, 1997.
DOI : 10.1016/S0169-2607(97)00020-5

M. Shelley, M. Andersen, and J. Fisher, An inhalation distribution model for the lactating mother and nursing child, Toxicology Letters, vol.43, issue.1-3, pp.23-29, 1988.
DOI : 10.1016/0378-4274(88)90018-5

J. Byczkowski and J. Fisher, Lactational Transfer of Tetrachloroethylene in Rats, Risk Analysis, vol.23, issue.356, pp.339-349, 1994.
DOI : 10.1016/0378-4274(88)90018-5

E. Fanning, Improving the biological basis for carcinogen risk assessment: benzene-induced leukemia as a case study, 1998.

K. Thomaseth and A. Salvan, Estimation of occupational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin using a minimal physiologic toxicokinetic model, Environmental Health Perspectives, vol.106, issue.Suppl 2, pp.743-753, 1998.
DOI : 10.1289/ehp.98106743

E. Adolph, Quantitative Relations in the Physiological Constitutions of Mammals, Science, vol.109, issue.2841, pp.579-585, 1949.
DOI : 10.1126/science.109.2841.579

H. Boxenbaum, Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics, Journal of Pharmacokinetics and Biopharmaceutics, vol.87, issue.2, pp.201-227, 1982.
DOI : 10.1007/BF01062336

H. Boxenbaum, Interspecies Pharmacokinetic Scaling and the Evolutionary-Comparative Paradigm, Drug Metabolism Reviews, vol.108, issue.6213, pp.1071-1121, 1984.
DOI : 10.1002/jps.2600570814

I. Davidson, J. Parker, and R. Beliles, Biological basis for extrapolation across mammalian species, Regulatory Toxicology and Pharmacology, vol.6, issue.3, pp.211-237, 1986.
DOI : 10.1016/0273-2300(86)90014-0

J. Mordenti, Man versus Beast: Pharmacokinetic Scaling in Mammals, Journal of Pharmaceutical Sciences, vol.75, issue.11, pp.1028-1040, 1986.
DOI : 10.1002/jps.2600751104

R. Ings, Interspecies scaling and comparisons in drug development and toxicokinetics, Xenobiotica, vol.75, issue.11, pp.1201-1231, 1990.
DOI : 10.3109/03602538409033558

C. Cobelli and J. Distefano, Parameter and structural identifiability concepts and ambiguities: a critical review and analysis, Am J Physiol, vol.242, issue.5, pp.7-24, 1980.

J. Jacquez, Identifiability, Fed Proc, vol.46, issue.8, pp.2477-2480, 1987.
DOI : 10.1016/S1043-4526(08)60036-4

J. Jacquez and T. Perry, Parameter estimation: local identifiability of parameters, Am J Physiol, vol.258, issue.4, pp.727-736, 1990.

K. Godfrey, M. Chapman, and S. Vajda, Identifiability and indistinguishability of nonlinear pharmacokinetic models, Journal of Pharmacokinetics and Biopharmaceutics, vol.22, issue.3, pp.229-251, 1994.
DOI : 10.1007/BF02353330

W. Slob, P. Janssen, and J. Van-den-hof, Structural Identifiability of PBPK Models: Practical Consequences for Modeling Strategies and Study Designs, Critical Reviews in Toxicology, vol.48, issue.3, pp.261-272, 1997.
DOI : 10.3109/10408449709089895

M. Omlin and P. Reichert, A comparison of techniques for the estimation of model prediction uncertainty, Ecological Modelling, vol.115, issue.1, pp.45-59, 1999.
DOI : 10.1016/S0304-3800(98)00174-4

W. Rowe, Understanding Uncertainty, Risk Analysis, vol.14, issue.5, pp.743-750, 1994.
DOI : 10.1111/j.1539-6924.1994.tb00284.x

D. Beatty and W. Piegorsch, Optimal statistical design for toxicokinetic studies, Statistical Methods in Medical Research, vol.3, issue.11, pp.359-376, 1997.
DOI : 10.1177/096228029700600405

F. Bois, T. Smith, A. Gelman, H. Chang, and A. Smith, Optimal design for a study of butadiene toxicokinetics in humans, Toxicological Sciences, vol.49, issue.2, pp.213-224, 1999.
DOI : 10.1093/toxsci/49.2.213

URL : https://hal.archives-ouvertes.fr/ineris-00962757

S. Beal and L. Sheiner, Methodology of population pharmacokinetics, In: Drug Fate and Metabolism Hirtz J, vol.5, pp.135-183, 1985.

A. Racine-poon and A. Smith, Population Models, Statistical Methodology in the Pharmaceutical Sciences
DOI : 10.1201/b16950-6

A. Smith, P. Ryan, and J. Evans, The Effect of Neglecting Correlations When Propagating Uncertainty and Estimating the Population Distribution of Risk, Risk Analysis, vol.12, issue.4, pp.467-474, 1992.
DOI : 10.1016/0951-8320(89)90013-6

R. Spear, F. Bois, T. Woodruff, D. Auslander, J. Parker et al., Modeling Benzene Pharmacokinetics Across Three Sets of Animal Data: Parametric Sensitivity and Risk Implications, Risk Analysis, vol.74, issue.4, pp.641-654, 1991.
DOI : 10.1016/0041-008X(84)90064-4

D. Hetrick, A. Jarabek, and C. Travis, Sensitivity analysis for physiologically based pharmacokinetic models, Journal of Pharmacokinetics and Biopharmaceutics, vol.17, issue.1, pp.1-20, 1991.
DOI : 10.1007/BF01062190

R. Rubinstein, Simulation and the Monte Carlo Method, 1981.

J. Hammersley and D. Handscomb, Monte Carlo Methods, 1964.

F. Hoffman and J. Hammonds, Propagation of Uncertainty in Risk Assessments: The Need to Distinguish Between Uncertainty Due to Lack of Knowledge and Uncertainty Due to Variability, Risk Analysis, vol.57, issue.104, pp.707-712, 1994.
DOI : 10.1111/j.1539-6924.1994.tb00281.x

S. Beal and L. Sheiner, Estimating population kinetics, CRC Crit Rev Biomed Eng, vol.8, pp.195-222, 1982.

L. Sheiner, The Population Approach to Pharmacokinetic Data Analysis: Rationale and Standard Data Analysis Methods, Drug Metabolism Reviews, vol.27, issue.1-2, pp.153-171, 1984.
DOI : 10.1214/aoms/1177706645

L. Yuh, S. Beal, M. Davidian, F. Harrison, A. Hester et al., Population Pharmacokinetic/Pharmacodynamic Methodology and Applications: A Bibliography, Biometrics, vol.50, issue.2, pp.566-575, 1994.
DOI : 10.2307/2533402

M. Davidian and D. Giltinian, Nonlinear Models for Repeated Measurements Data, 1995.

F. Bois, E. Jackson, K. Pekari, and M. Smith, Population toxicokinetics of benzene, Environmental Health Perspectives, vol.104, issue.Suppl 6, pp.1405-1411, 1996.
DOI : 10.1289/ehp.961041405

P. Droz, M. Wu, W. Cumberland, and M. Berode, Variability in biological monitoring of solvent exposure. I: Development and validation of a population model, Br J Ind Med, vol.46, pp.447-460, 1989.

P. Droz, M. Wu, and W. Cumberland, Variability in biological monitoring of organic solvent exposure. II. Application of a population physiological model., Occupational and Environmental Medicine, vol.46, issue.8, pp.547-558, 1989.
DOI : 10.1136/oem.46.8.547

A. Mallet, F. Mentre, J. Steimer, and F. Lokiec, Nonparametric maximum likelihood estimation for population pharmacokinetics, with application to cyclosporine, Journal of Pharmacokinetics and Biopharmaceutics, vol.14, issue.3, pp.311-327, 1988.
DOI : 10.1007/BF01062140

A. Schumitzky, Nonparametric EM Algorithms for estimating prior distributions, Applied Mathematics and Computation, vol.45, issue.2, pp.141-157, 1991.
DOI : 10.1016/0096-3003(91)90077-Z

M. Davidian and A. Gallant, Smooth nonparametric maximum likelihood estimation for population pharmacokinetics, with application to quinidine, Journal of Pharmacokinetics and Biopharmaceutics, vol.11, issue.60, pp.529-556, 1992.
DOI : 10.1007/BF01061470

A. Mallet, A maximum likelihood estimation method for random coefficient regression models, Biometrika, vol.73, issue.3, pp.645-656, 1986.
DOI : 10.1093/biomet/73.3.645

M. Lindstrom and D. Bates, Nonlinear Mixed Effects Models for Repeated Measures Data, Biometrics, vol.46, issue.3, pp.673-687, 1990.
DOI : 10.2307/2532087

A. Racine-poon, A Bayesian Approach to Nonlinear Random Effects Models, Biometrics, vol.41, issue.4, pp.1015-1023, 1985.
DOI : 10.2307/2530972

J. Wakefield, A. Smith, A. Racine-poon, and A. Gelfand, Bayesian Analysis of Linear and Non-Linear Population Models by Using the Gibbs Sampler, Applied Statistics, vol.43, issue.1, pp.201-221, 1994.
DOI : 10.2307/2986121

J. Bernardo and A. Smith, Bayesian Theory, 1994.
DOI : 10.1002/9780470316870

A. Gelman, B. Carlin, H. Stern, and D. Rubin, Bayesian Data Analysis, 1995.

D. Spiegelhalter, J. Myles, D. Jones, and K. Abrams, Methods in health service research: An introduction to bayesian methods in health technology assessment, BMJ, vol.319, issue.7208, pp.508-512, 1999.
DOI : 10.1136/bmj.319.7208.508

S. Lauritzen and D. Spiegelhalter, Local computations with probabilities on graphical structures and their application to expert systems, J Roy Stat Soc B, vol.50, pp.157-194, 1988.

J. Whittaker, Graphical Models in Applied Mutivariate Analysis, 1990.

J. Pearl, Causal diagrams for empirical research, Biometrika, vol.82, issue.4, pp.669-710, 1995.
DOI : 10.1093/biomet/82.4.669

A. Gelman and D. Rubin, Markov chain Monte Carlo methods in biostatistics, Statistical Methods in Medical Research, vol.80, issue.4, pp.339-355, 1996.
DOI : 10.1177/096228029600500402

W. Gilks, S. Richardson, and D. Spiegelhalter, Markov Chain Monte Carlo in Practice, 1996.

A. Monster, G. Boersma, and H. Steenweg, Kinetics of tetrachloroethylene in volunteers; influence of exposure concentration and work load, International Archives of Occupational and Environmental Health, vol.20, issue.3-4, pp.303-309, 1979.
DOI : 10.1007/BF00377784

G. Datta and M. Ghosh, Some Remarks on Noninformative Priors, Journal of the American Statistical Association, vol.25, issue.432, pp.1357-1363, 1995.
DOI : 10.1016/0378-3758(94)90023-X

R. Kass and L. Wasserman, The Selection of Prior Distributions by Formal Rules, Journal of the American Statistical Association, vol.36, issue.435, pp.1343-1370, 1996.
DOI : 10.1080/01621459.1996.10477003

G. Box and G. Tiao, Bayesian Inference in Statistical Analysis, 1973.
DOI : 10.1002/9781118033197

A. Smith, Bayesian Computational Methods, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, vol.337, issue.1647, pp.369-386, 1991.
DOI : 10.1098/rsta.1991.0130

A. Gelman and D. Rubin, Inference from Iterative Simulation Using Multiple Sequences, Statistical Science, vol.7, issue.4, pp.457-511, 1992.
DOI : 10.1214/ss/1177011136

M. Cowles and B. Carlin, Markov Chain Monte Carlo Convergence Diagnostics: A Comparative Review, Journal of the American Statistical Association, vol.90, issue.434, pp.883-904, 1996.
DOI : 10.1080/01621459.1996.10476956

C. Geyer and E. Thompson, Annealing Markov Chain Monte Carlo with Applications to Ancestral Inference, Journal of the American Statistical Association, vol.167, issue.431, pp.909-920, 1995.
DOI : 10.1080/01621459.1995.10476507

W. Gilks, R. Cgilks, W. Richardson, S. Speigelhalter, and D. , Strategies for improving MCMC In: Markov Chain Monte Carlo in Practice, pp.89-114, 1996.

L. Tierney and M. A. , Some adaptive Monte Carlo methods for Bayesian inference, Statistics in Medicine, vol.43, issue.17-18, pp.2507-2515, 1888.
DOI : 10.1002/(SICI)1097-0258(19990915/30)18:17/18<2507::AID-SIM272>3.0.CO;2-J

D. Sargent, J. Hodges, and B. Carlin, Structured Markov Chain Monte Carlo, Journal of Computational and Graphical Statistics, vol.92, issue.2, pp.217-234, 2000.
DOI : 10.1080/10618600.2000.10474877

T. Smith, Pharmacokinetic models in the development of exposure indicators in epidemiology, Ann Occup Hyg, vol.35, pp.543-560, 1991.

J. Wakefield and J. Bennett, The Bayesian Modeling of Covariates for Population Pharmacokinetic Models, Journal of the American Statistical Association, vol.43, issue.435, pp.917-927, 1996.
DOI : 10.2307/2986121

F. Bois, Analysis of PBPK Models for Risk Characterization, Annals of the New York Academy of Sciences, vol.43, issue.9, pp.317-337, 1999.
DOI : 10.1016/0041-008X(90)90037-U

URL : https://hal.archives-ouvertes.fr/ineris-00962759

F. Bois, Statistical Analysis of Clewell et al. PBPK Model of Trichloroethylene Kinetics, Environmental Health Perspectives, vol.108, issue.s2, pp.307-316, 2000.
DOI : 10.1289/ehp.00108s2307

URL : https://hal.archives-ouvertes.fr/ineris-00961854